Michele Duong Granada, MD
Internal Medicine · Minneapolis
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 27 years
- Graduated 1999
Offices
3 locations · Allina Health System · Bay Area Community Health · Indianhead Medical Center Shell Lake, Inc.
Looking this up.
Hospitals listed: Abbott Northwestern Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Granada’s office to ask if they take your plan before you enroll.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Abbott Northwestern HospitalMinneapolis, MNAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Allina Health, which runs 13 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.588, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.404, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.085, Oct 2024 – Sep 2025
See every measure and the patient survey for Abbott Northwestern Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.588 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.404 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.45 to 2.11) · 2,714 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.76 to 1.18) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 187.54 (147.32 to 227.75) · 196 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.4 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 397 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 355 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 562 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 7,586 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.32) · 11,025 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.09 to 0.43) · 11,717 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.55 (2.03 to 5.07) · 4,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.49 (1.33 to 3.66) · 2,418 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.74 (0.6 to 2.88) · 3,788 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.94 (7.42 to 14.46) · 2,411 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.45 (4.02 to 8.89) · 2,465 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.4 (0.03 to 2.76) · 1,030 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.63) · 8,858 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3 · 393 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.764 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.921 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 907 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.7 · 1,450 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3 · 460 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -20 · 787 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.1 · 379 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 673 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 7.8) · 91 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.6 (7.5 to 14.7) · 91 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 419 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.1 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 216 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.9 (11.2 to 19.7) · 232 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 641 cases | No different | Jan 2024 – Dec 2024 |
What patients said (508 patients answered, 28% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 61% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$57,287
Medicare paid this office $57,287 for 202 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $23,205 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 115 | $11,304 | $94 |
| Long return visit (40+ min) | 28 | $6,359 | $130 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $5,978 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $5,380 | $58 |
See all 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $23,205 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 115 | $11,304 | $94 |
| Long return visit (40+ min) | 28 | $6,359 | $130 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $5,978 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $5,380 | $58 |
| Return visit (30+ min) | 20 | $3,116 | $92 |
Who their Medicare patients are
202 Original Medicare patients in 2024. Average age 70 · Under 65 25% · 85 and older 10% · Women 48% · Also on Medicaid 34% · Health risk score 3.16. Above the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Chronic kidney disease 55% · Depression 50% · Diabetes 48% · Coronary heart disease 46% · Heart failure 45% · Atrial fibrillation 40% · COPD 27% · Cancer 25% · Dementia 18% · Stroke 14%.
The office billed $335,593, Medicare allowed $73,501 and paid $57,287; for 628 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 202 | 628 | 70 | 3.16 | $335,593 | $57,287 |
| 2023 | 201 | 589 | 69 | 2.92 | $287,973 | $54,249 |
| 2022 | 300 | 772 | 72 | 2.56 | $175,995 | $61,498 |
| 2021 | 529 | 1,544 | 72 | 2.58 | $311,051 | $121,800 |
| 2020 | 537 | 1,352 | 72 | 2.63 | $272,837 | $108,737 |
| 2019 | 525 | 1,588 | 71 | 2.84 | $324,074 | $127,007 |
| 2018 | 556 | 1,717 | 70 | 3.00 | $374,708 | $128,376 |
| 2017 | 567 | 1,814 | 70 | 2.93 | $398,919 | $136,484 |
| 2016 | 595 | 2,070 | 70 | 2.87 | $457,126 | $156,573 |
| 2015 | 594 | 5,504 | 69 | 2.86 | $446,220 | $151,580 |
| 2014 | 595 | 4,307 | 69 | 2.78 | $439,282 | $150,520 |
| 2013 | 374 | 1,588 | 69 | 2.94 | $214,296 | $72,593 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 76 | $19,197 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 106 | $10,829 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $8,206 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $6,749 | $132 |
| Long return visit (40+ min) | 27 | $5,685 | $135 |
| Return visit (30+ min) | 13 | $1,274 | $85 |
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 186 | $33,582 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 91 | $9,271 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $7,110 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $6,539 | $145 |
| Return visit (30+ min) | 16 | $1,337 | $58 |
2021: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 326 | $58,461 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 186 | $20,094 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 209 | $19,963 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $11,767 | $151 |
| Return visit (30+ min) | 35 | $4,136 | $73 |
| Long return visit (40+ min) | 16 | $3,354 | $112 |
2020: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 360 | $57,158 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 185 | $16,254 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 119 | $12,945 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $12,896 | $154 |
| Return visit (30+ min) | 35 | $2,407 | $56 |
| Return visit (30+ min) | 19 | $1,661 | $69 |
| Long return visit (40+ min) | 13 | $1,635 | $86 |
2019: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 318 | $56,839 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 207 | $21,336 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $15,232 | $152 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 122 | $12,731 | $101 |
| Long return visit (40+ min) | 34 | $6,697 | $105 |
| Return visit (30+ min) | 42 | $5,022 | $78 |
| New patient visit (45+ min) | 11 | $1,280 | $116 |
| Return visit (30+ min) | 16 | $1,070 | $59 |
2018: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 317 | $53,956 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 249 | $24,973 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 145 | $14,503 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $11,024 | $153 |
| Return visit (30+ min) | 66 | $7,833 | $73 |
| Long return visit (40+ min) | 34 | $5,638 | $106 |
| Return visit (30+ min) | 28 | $1,755 | $57 |
| New patient visit (45+ min) | 12 | $1,454 | $121 |
| Short return visit (20+ min) | 22 | $1,087 | $49 |
2017: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 293 | $51,220 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 308 | $33,533 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 105 | $17,039 | $152 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 136 | $14,504 | $101 |
| Return visit (30+ min) | 84 | $9,773 | $76 |
| Long return visit (40+ min) | 19 | $2,512 | $87 |
| New patient visit (45+ min) | 15 | $1,471 | $98 |
| Short return visit (20+ min) | 23 | $1,352 | $50 |
| Long return visit (40+ min) | 12 | $1,004 | $77 |
| Return visit (30+ min) | 15 | $888 | $59 |
2016: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 350 | $80,211 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 255 | $26,191 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $17,609 | $148 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 118 | $12,101 | $100 |
| Return visit (30+ min) | 53 | $6,890 | $77 |
| Return visit (30+ min) | 31 | $2,412 | $56 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 25 | $2,036 | $73 |
| New patient visit (45+ min) | 15 | $1,698 | $113 |
| Short return visit (20+ min) | 22 | $1,233 | $51 |
| Short return visit (20+ min) | 11 | $421 | $38 |
2015: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 430 | $55,662 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 150 | $27,090 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 93 | $14,200 | $148 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 137 | $13,735 | $97 |
| Return visit (30+ min) | 44 | $5,362 | $56 |
| Return visit (30+ min) | 37 | $3,672 | $71 |
| Short return visit (20+ min) | 54 | $3,203 | $36 |
| Short return visit (20+ min) | 35 | $2,569 | $52 |
| New patient visit (30+ min) | 15 | $799 | $53 |
2014: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 415 | $59,663 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 137 | $25,207 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 145 | $16,279 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $8,098 | $145 |
| Return visit (30+ min) | 35 | $4,367 | $75 |
| Return visit (30+ min) | 30 | $2,998 | $57 |
| New patient visit (45+ min) | 18 | $1,866 | $104 |
| Short return visit (20+ min) | 25 | $1,844 | $53 |
| Short return visit (20+ min) | 36 | $1,757 | $34 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,505 | $75 |
| New patient visit (30+ min) | 20 | $963 | $48 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $824 | $46 |
2013: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 225 | $22,465 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $12,199 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 105 | $11,147 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $7,178 | $150 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 45 | $1,993 | $29 |
| Return visit (30+ min) | 22 | $1,957 | $72 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 25 | $1,936 | $77 |
| Return visit (30+ min) | 17 | $1,304 | $57 |
| Short return visit (20+ min) | 19 | $1,128 | $45 |
| New patient visit (45+ min) | 11 | $950 | $86 |
| Short return visit (20+ min) | 14 | $807 | $37 |
Medicaid work
$3,973 in 2023
Medicaid paid $3,973 for 51 billed services this clinician did in 2023, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 35 | $2,377 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 16 | $1,597 |
| 2023 | 51 | 2 | 18 | $3,973 |
| 2022 | 376 | 2 | 24 | $16,664 |
| 2021 | 903 | 3 | 31 | $43,126 |
| 2020 | 614 | 2 | 30 | $25,385 |
| 2019 | 727 | 4 | 30 | $28,998 |
| 2018 | 714 | 3 | 28 | $27,469 |
See the largest Medicaid services in earlier years
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 347 | $15,935 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 29 | $729 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 607 | $29,985 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 222 | $8,045 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 74 | $5,096 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 449 | $19,931 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 165 | $5,454 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 518 | $22,619 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 184 | $4,697 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $1,005 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $677 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 477 | $21,021 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 222 | $5,509 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 15 | $939 |
Drugs they prescribed that Part D paid
$104,652
Pharmacies billed $104,652 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 476) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
437 generic and 39 brand-name prescriptions · $104,652 in drug cost · 400 antibiotic prescriptions to 99 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vancomycin | 55 | $6,741 | $123 |
| Fosfomycin Tromethamine | 21 | $4,331 | $206 |
| Cefazolin | 30 | $2,391 | $80 |
| Cefadroxil | 53 | $1,138 | $21 |
| Ceftriaxone | 35 | $874 | $25 |
See all 11 drugs
| Vancomycin | 55 | $6,741 | $123 |
| Fosfomycin Tromethamine | 21 | $4,331 | $206 |
| Cefazolin | 30 | $2,391 | $80 |
| Cefadroxil | 53 | $1,138 | $21 |
| Ceftriaxone | 35 | $874 | $25 |
| Doxycycline Hyclate | 34 | $831 | $24 |
| Amoxicillin-Clavulanate Potass | 21 | $529 | $25 |
| Amoxicillin | 40 | $369 | $9 |
| Fluconazole | 16 | $368 | $23 |
| Levofloxacin | 19 | $177 | $9 |
| Sulfamethoxazole-Trimethoprim | 23 | $164 | $7 |
Year by year
| 2024 | 476 | 103 | 0% (0) | 8% | $104,652 |
| 2023 | 258 | 78 | 0% (0) | None | $102,774 |
| 2022 | 275 | 65 | 0% (0) | 20% | $168,459 |
| 2021 | 617 | 121 | 0% (0) | 11% | $222,696 |
| 2020 | 606 | 102 | 0% (0) | 21% | $257,734 |
| 2019 | 712 | 121 | 0% (0) | 19% | $274,366 |
| 2018 | 766 | 142 | 0% (0) | 16% | $180,718 |
| 2017 | 619 | 114 | None | 14% | $146,637 |
| 2016 | 420 | 121 | 0% (0) | 7% | $141,892 |
| 2015 | 356 | 101 | None | 11% | $81,302 |
| 2014 | 318 | 89 | None | 17% | $127,074 |
| 2013 | 237 | 62 | None | None | $24,084 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Ceftriaxone | 19 | $3,790 | $199 |
| Cefazolin | 33 | $2,205 | $67 |
| Nitrofurantoin Mono-Macro | 19 | $1,389 | $73 |
| Cefadroxil | 20 | $1,292 | $65 |
| Methenamine Hippurate | 15 | $1,290 | $86 |
| Amoxicillin-Clavulanate Potass | 11 | $373 | $34 |
| Amoxicillin | 15 | $125 | $8 |
2022: 8 drugs
| Triumeq | 13 | $47,349 | $3,642 |
| Genvoya | 11 | $42,576 | $3,871 |
| Emtricitabine-Tenofovir Disop | 21 | $15,369 | $732 |
| Itraconazole | 15 | $4,360 | $291 |
| Cefazolin | 37 | $3,956 | $107 |
| Ceftriaxone | 25 | $809 | $32 |
| Amoxicillin | 18 | $353 | $20 |
| Cephalexin | 12 | $283 | $24 |
2021: 16 drugs
| Genvoya | 12 | $42,761 | $3,563 |
| Daptomycin | 34 | $38,223 | $1,124 |
| Emtricitabine-Tenofovir Disop | 23 | $26,577 | $1,156 |
| Tivicay | 13 | $26,056 | $2,004 |
| Itraconazole | 25 | $6,465 | $259 |
| Ceftriaxone | 84 | $4,779 | $57 |
| Vancomycin | 29 | $2,929 | $101 |
| Cefepime | 16 | $2,242 | $140 |
| Doxycycline Hyclate | 31 | $2,039 | $66 |
| Ceftazidime | 29 | $1,793 | $62 |
| Cefazolin | 31 | $1,765 | $57 |
| Levofloxacin | 23 | $627 | $27 |
| Cephalexin | 36 | $505 | $14 |
| Amoxicillin-Clavulanate Potass | 13 | $289 | $22 |
| Ethambutol | 13 | $266 | $20 |
| Amoxicillin | 38 | $244 | $6 |
2020: 26 drugs
| Genvoya | 17 | $57,514 | $3,383 |
| Truvada | 24 | $45,467 | $1,894 |
| Tivicay | 20 | $37,888 | $1,894 |
| Daptomycin | 11 | $17,072 | $1,552 |
| Ampicillin | 19 | $5,439 | $286 |
| Rifabutin | 14 | $4,118 | $294 |
| Vancomycin | 42 | $4,058 | $97 |
| Itraconazole | 17 | $3,986 | $234 |
| Cefazolin | 32 | $2,662 | $83 |
| Colcrys | 11 | $2,511 | $228 |
| Cefepime | 13 | $2,326 | $179 |
| Ampicillin-Sulbactam | 16 | $1,913 | $120 |
| Doxycycline Hyclate | 28 | $1,421 | $51 |
| Ceftriaxone | 22 | $1,040 | $47 |
| Valacyclovir | 23 | $1,017 | $44 |
| Ethambutol | 22 | $944 | $43 |
| Azithromycin | 20 | $687 | $34 |
| Fenofibrate | 12 | $378 | $32 |
| Cephalexin | 21 | $343 | $16 |
| Amoxicillin-Clavulanate Potass | 15 | $297 | $20 |
| Levofloxacin | 18 | $184 | $10 |
| Amoxicillin | 20 | $145 | $7 |
| Lorazepam | 11 | $137 | $12 |
| Famotidine | 16 | $135 | $8 |
| Sulfamethoxazole-Trimethoprim | 18 | $88 | $5 |
| Metoprolol | 12 | $24 | $2 |
2019: 28 drugs
| Tivicay | 29 | $60,966 | $2,102 |
| Genvoya | 13 | $41,724 | $3,210 |
| Truvada | 20 | $36,683 | $1,834 |
| Prezista | 13 | $23,094 | $1,776 |
| Vancomycin | 34 | $12,792 | $376 |
| Ritonavir | 13 | $3,269 | $251 |
| Omega-3 Acid Ethyl Esters | 12 | $2,394 | $200 |
| Doxycycline Hyclate | 23 | $1,892 | $82 |
| Itraconazole | 11 | $1,800 | $164 |
| Cefazolin | 30 | $1,774 | $59 |
| Valacyclovir | 32 | $1,264 | $40 |
| Ceftriaxone | 35 | $1,190 | $34 |
| Cephalexin | 70 | $1,118 | $16 |
| Rifampin | 18 | $1,028 | $57 |
| Ethambutol | 20 | $910 | $45 |
| Azithromycin | 15 | $621 | $41 |
| Minocycline | 22 | $603 | $27 |
| Fluconazole | 17 | $596 | $35 |
| Amoxicillin | 30 | $397 | $13 |
| Metronidazole | 11 | $364 | $33 |
| Amoxicillin-Clavulanate Potass | 15 | $362 | $24 |
| Fenofibrate | 12 | $362 | $30 |
| Levofloxacin | 24 | $263 | $11 |
| Lorazepam | 14 | $261 | $19 |
| Sulfamethoxazole-Trimethoprim | 20 | $104 | $5 |
| Allopurinol | 12 | $80 | $7 |
| Ranitidine | 12 | $72 | $6 |
| Metoprolol | 12 | $42 | $4 |
2018: 26 drugs
| Tivicay | 20 | $34,815 | $1,741 |
| Truvada | 19 | $33,137 | $1,744 |
| Genvoya | 11 | $31,430 | $2,857 |
| Vancomycin | 15 | $4,390 | $293 |
| Cefazolin | 73 | $3,955 | $54 |
| Ampicillin | 25 | $3,745 | $150 |
| Omega-3 Acid Ethyl Esters | 12 | $2,394 | $200 |
| Rifampin | 31 | $2,075 | $67 |
| Ceftriaxone | 47 | $2,014 | $43 |
| Colchicine | 12 | $1,952 | $163 |
| Cephalexin | 85 | $1,505 | $18 |
| Minocycline | 31 | $923 | $30 |
| Ethambutol | 20 | $909 | $45 |
| Nyamyc | 12 | $820 | $68 |
| Azithromycin | 15 | $782 | $52 |
| Levofloxacin | 37 | $680 | $18 |
| Valacyclovir | 21 | $582 | $28 |
| Ondansetron | 11 | $399 | $36 |
| Amoxicillin-Clavulanate Potass | 18 | $395 | $22 |
| Fenofibrate | 12 | $350 | $29 |
| Rosuvastatin | 12 | $257 | $21 |
| Amoxicillin | 15 | $159 | $11 |
| Sulfamethoxazole-Trimethoprim | 14 | $127 | $9 |
| Allopurinol | 12 | $72 | $6 |
| Ranitidine | 12 | $72 | $6 |
| Metoprolol | 12 | $42 | $4 |
2017: 17 drugs
| Itraconazole | 48 | $21,601 | $450 |
| Tivicay | 13 | $19,979 | $1,537 |
| Vancomycin | 40 | $10,721 | $268 |
| Ampicillin | 15 | $4,182 | $279 |
| Doxycycline Hyclate | 24 | $2,135 | $89 |
| Cefazolin | 37 | $1,952 | $53 |
| Minocycline | 40 | $1,398 | $35 |
| Azithromycin | 14 | $859 | $61 |
| Ceftriaxone | 28 | $826 | $30 |
| Rifampin | 16 | $673 | $42 |
| Metronidazole | 18 | $670 | $37 |
| Cephalexin | 57 | $649 | $11 |
| Amoxicillin-Clavulanate Potass | 17 | $567 | $33 |
| Valacyclovir | 12 | $195 | $16 |
| Amoxicillin | 20 | $113 | $6 |
| Levofloxacin | 11 | $99 | $9 |
| Metoprolol | 12 | $93 | $8 |
2016: 13 drugs
| Vancomycin | 32 | $5,310 | $166 |
| Ampicillin-Sulbactam | 20 | $3,465 | $173 |
| Fluconazole | 13 | $1,693 | $130 |
| Doxycycline Hyclate | 16 | $1,665 | $104 |
| Rifampin | 21 | $1,603 | $76 |
| Cefazolin | 19 | $857 | $45 |
| Ceftriaxone | 18 | $842 | $47 |
| Minocycline | 32 | $833 | $26 |
| Cephalexin | 47 | $551 | $12 |
| Metronidazole | 12 | $444 | $37 |
| Levofloxacin | 14 | $386 | $28 |
| Sulfamethoxazole-Trimethoprim | 22 | $209 | $9 |
| Amoxicillin | 21 | $130 | $6 |
2015: 13 drugs
| Vancomycin | 38 | $5,679 | $149 |
| Ceftriaxone | 27 | $1,783 | $66 |
| Ampicillin-Sulbactam | 15 | $1,614 | $108 |
| Cefazolin | 28 | $1,596 | $57 |
| Cefepime | 13 | $1,376 | $106 |
| Fluconazole | 18 | $917 | $51 |
| Rifampin | 11 | $789 | $72 |
| Minocycline | 22 | $552 | $25 |
| Cephalexin | 35 | $322 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $208 | $19 |
| Levofloxacin | 16 | $148 | $9 |
| Amoxicillin | 14 | $112 | $8 |
| Sulfamethoxazole-Trimethoprim | 17 | $102 | $6 |
2014: 10 drugs
| Cubicin | 19 | $57,037 | $3,002 |
| Nafcillin | 13 | $7,551 | $581 |
| Vancomycin | 29 | $6,664 | $230 |
| Invanz | 12 | $5,045 | $420 |
| Ampicillin | 29 | $4,007 | $138 |
| Ampicillin-Sulbactam | 24 | $2,033 | $85 |
| Cefazolin | 24 | $1,004 | $42 |
| Ceftriaxone | 22 | $993 | $45 |
| Levofloxacin | 17 | $909 | $53 |
| Minocycline | 18 | $302 | $17 |
2013: 7 drugs
| Nafcillin | 15 | $11,820 | $788 |
| Vancomycin | 58 | $5,227 | $90 |
| Cefazolin | 16 | $896 | $56 |
| Ciprofloxacin | 28 | $695 | $25 |
| Minocycline | 21 | $539 | $26 |
| Fluconazole | 11 | $490 | $45 |
| Amoxicillin | 15 | $192 | $13 |
Money from drug and device companies
$174 in 2020
| 2020 | 2 | 4 | None | $174 |
| 2019 | 2 | 4 | None | $256 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | Biktarvy | $125 | 1 payment
|
| Insmed | None | $49 | 3 payments
|
See all 4 published payments
| Insmed | Education · 2020-12-17 | None | $16 |
| Insmed | Education · 2020-12-09 | None | $16 |
| Insmed | Education · 2020-10-14 | None | $16 |
| Gilead Sciences | Meals · 2020-02-27 | Biktarvy | $125 |
See earlier years (2019)
2019: $256
| Insmed | Arikayce | $158 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $98 | 1 payment
|
Professional record
- NPI
- 1487971941
- Licence
- IA MD-40831, MN 71635, PA MD39944
- Group
- Allina Health System · Bay Area Community Health · Indianhead Medical Center Shell Lake, Inc.
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 2925 Chicago Ave, Minneapolis, MN, 55407
- NPI first listed
- 2010-04-23
- NPI last updated
- 2022-10-04
- NPI record certified
- 2022-10-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 411 Laurel St Ste A120, Des Moines, IA, 50314
This office lists an electronic records connection.